logo

[breadcrumb_custom]

ELEV: Riding the Market Waves of Growth and Decline in 2023

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 440.04%.However, over the last six months, we can see a weaker performance of 271.79%. Over the last 30 days, the price of ELEV has fallen by 18.37%. And in the last five days, it has fallen by -1.69%.

Elevation Oncology Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $5.89 on 05/26/23 and the lowest value was $0.36 on 11/13/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

52-week price history of ELEV Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Elevation Oncology Inc’s current trading price is -50.76% away from its 52-week high, while its distance from the 52-week low is 698.90%. The stock’s price range during this period has varied between$0.36 and $5.89. The Elevation Oncology Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.66 million for the day, a figure considerably lower than their average daily volume of 2.7 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Elevation Oncology Inc (ELEV) has experienced a quarterly rise of 528.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 122.99M and boasts a workforce of 33 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.27, with a change in price of +2.23. Similarly, Elevation Oncology Inc recorded 1,779,534 in trading volume during the last 100 days, posting a change of +329.63%.

ELEV’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ELEV stands at 0.48. Similarly, the long-term debt-to-equity ratio is also 0.48.

ELEV Stock Stochastic Average

Elevation Oncology Inc’s raw stochastic average for the past 50 days is presently 82.00%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 42.55%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 28.37% and 30.91%, respectively.

On Key

Related Posts